DDW 2021: Retrospective Data Demonstrate Effectiveness of Ustekinumab Over Vedolizumab for Crohn’s Disease
While both agents worked well, ustekinumab did have a slight edge
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.